|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||104.34 - 106.06|
|52-week range||98.38 - 135.89|
|Beta (5Y monthly)||0.75|
|PE ratio (TTM)||29.08|
|Earnings date||26 May 2022|
|Forward dividend & yield||2.52 (2.39%)|
|Ex-dividend date||24 Mar 2022|
|1y target est||123.01|
Medtronic's (MDT) Cardiovascular business is expected to have gained share in both high and low power devices in Q4.
The stock market has been struggling all year, and before long, all three major U.S. indexes could find themselves in bear market territory. While that sounds unnerving, investors can seek refuge in the market by looking at those industries whose businesses remain somewhat stable regardless of market and economic conditions. The healthcare sector fits the bill.
Medtronic (MDT) closed the most recent trading day at $102.75, moving -0.79% from the previous trading session.